Showing results (101-110 of 588) with videos related to
Sort By:
Pageof 59
The Journal of Molecular Diagnostics : JMD|June 27, 2007
Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sampleShuji Ogino, Takako Kawasaki, Gregory J Kirkner, et al.The American Journal of Dermatopathology|June 28, 2017
Fatty Acid Synthase and Acetyl-CoA Carboxylase Are Expressed in Nodal Metastatic Melanoma But Not in Benign Intracapsular Nodal NeviJad Saab, Maria Laureana Santos-Zabala, Massimo Loda, et al.Cancer Research|June 17, 2005
Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumorsJames V Alvarez, Phillip G Febbo, Sridhar Ramaswamy, et al.Cancer Discovery|May 29, 2014
Vulnerabilities of PTEN-TP53-deficient prostate cancers to compound PARP-PI3K inhibitionEnrique González-Billalabeitia, Nina Seitzer, Su Jung Song, et al.The Journal of Urology|April 12, 2005
Androgen mediated regulation and functional implications of fkbp51 expression in prostate cancerPhillip G Febbo, Mark Lowenberg, Aaron R Thorner, et al.Nature Genetics|September 5, 2020
Author Correction: A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancerAndrea Lunardi, Ugo Ala, Mirjam T Epping, et al.The Journal of Biological Chemistry|July 4, 2002
Molecular cloning and characterization of STAMP1, a highly prostate-specific six transmembrane protein that is overexpressed in prostate cancerKemal S Korkmaz, Cem Elbi, Ceren G Korkmaz, et al.Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|November 29, 2007
Evaluation of whole genome amplification protocols for array and oligonucleotide CGHAdam Hittelman, Shivaranjani Sridharan, Ritu Roy, et al.Cancer Research|March 20, 2015
26th Pezcoller symposium: cancers driven by hormonesMyles Brown, Arul Chinnaiyan, Antonella Farsetti, et al.Nature Genetics|June 4, 2013
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancerAndrea Lunardi, Ugo Ala, Mirjam T Epping, et al.Pageof 59